Neuroleptic dose reduction in persistently psychotic patients.
Faraone
S V
SV
Psychiatry Service, VA Medical Center, Brockton, Massachusetts 02401.
Green
A I
AI
Brown
W
W
Yin
P
P
Tsuang
M T
MT
D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004409:Dyskinesia, Drug-Induced / Q000517:prevention & control; D005476:Fluphenazine / Q000008:administration & dosage / Q000031:analogs & derivatives; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011618:Psychotic Disorders / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology
D014150:Antipsychotic Agents; C011825:fluphenazine depot; D005476:Fluphenazine